Adequate Bone Marrow Function defined as:\r\n* Peripheral absolute phagocyte count (APC) > 1000/ µL; APC = numbers of banded neutrophils + segmented neutrophils + metamyelocytes + monocytes + eosinophils Please note, if institution reports differential as a percentage, then APC = [percentage of banded neutrophils + segmented neutrophils+ metamyelocytes+monocytes+eosinophils] x total white cell count.\r\n* Platelet Count > 100,000/µL (transfusion independent)\r\n* Hemoglobin > 8 gm/dL (may have received RBC transfusions)
Neutrophils >= 1000/uL
Neutrophils >= 1.5 x 10^9/L (for treatment phase)
Neutrophils >= 1.5 x 10^9/L
Neutrophils >= 1.5 x 10^9/L
Neutrophils >1,000 µL
Neutrophils ?1,500 ?L.
Obtained within 14 days prior to C1D1: Neutrophils >= 1500/uL
Neutrophils < 1,500 cells/µL.
Neutrophils ?1000/?L (?1 x 10^9/L)
Two out of three of the following (in peripheral blood): Neutrophils < 0.5 x10^9/L, Platelets < 20 x10^9/L, or Reticulocyte count < 20 x10^9/L
Neutrophils >= 1500
Within 14 days of the first dose of study drug: Neutrophils >= 1500/uL
Neutrophils >= 1500/uL.
Obtained within 14 days prior to randomization/registration: neutrophils >= 1500/uL
Neutrophils >= 1500/uL within 14 days of registration
Obtained within 21 days prior to randomization/registration: Neutrophils >= 1500/uL.
Absolute neutrophils > 1,500/µL
STUDY TREATMENT: Neutrophils >= 1500/ul
Neutrophils >= 1500/uL
Neutrophils >= 1500/uL
Neutrophils (Neuts) >= 1500/uL, within 30 days before study registration
Neutrophils >= 1500/uL within 14 days prior to first dose
Neutrophils >= 1500/uL
Obtained within 14 days of randomization: Neutrophils >= 1500/uL
Neutrophils < 1,500/mm^3
Neutrophils ?1.5 x 10^9/L
Neutrophils >= 1500/uL
Neutrophils >= 1500 /uL
Neutrophils >= 1.5 x 10^9 /L
Neutrophils >= 1500/uL
Absolute neutrophils >= 1500/mm^3, within 14 day prior to registration
Neutrophils >= 1500/uL obtained within 14 days prior to randomization/registration
Neutrophils >= 1500/uL
Neutrophils >= 1500/uL
Adequate hematologic function, as defined by neutrophils ? 1.0 x 10^9/L and platelets ? 50 x 10^9/L; patients with neutrophils < 1.0 x 10^9/L due to marrow infiltration are allowed to receive growth factors to bring pre-treatment neutrophils to ? 1.0 x 10^9/L.
Absolute neutrophils >= 1,500/mm^3
Absolute neutrophils >= 1500/mm^3.
Neutrophils >= 1500/uL
Absolute neutrophils > 1,500/uL
Absolute phagocyte count (APC = neutrophils and monocytes): >= 1000/mm^3
Neutrophils >= 1,500 cells/uL
Neutrophils >= 1500 cells/uL
Patients in CRi must have evidence of hematologic recovery after prior therapy to at least: absolute neutrophils >= 0.8 x 10^9/L
Neutrophils >= 1500 cells/uL
Neutrophils >= 1500/uL
Neutrophils > 1500/uL
Neutrophils >= 1500/uL
Neutrophils > 1.5 x 10^9/L
Absolute neutrophils count >= 1,500/mcL
Neutrophils >= 1.5 x 10^9 cells/L
Absolute neutrophils count >= 1500/mcl
Neutrophils > 1,000/uL prior to day 0
Neutrophils > 1000/uL
Neutrophils > 1500/uL
Neutrophils > 1000/uL
Neutrophils >= 1500/uL
Neutrophils >= 0.5 x 10^9/L, unless cytopenias are deemed due to disease
Neutrophils > 1500/uL
Neutrophils >= 1,000/ul
Neutrophils ? 1.5x109/L
Neutrophils >= 1.5 K/microliter should be obtained with 28 days prior to randomization
Neutrophils >= 1.5 x 10^9/L
Neutrophils ? 1500/µL
Neutrophils >= 1,500
Neutrophils >= 1250
Absolute Neutrophils Count (ANC) ? 1.5 x 109/L
Neutrophils > 1000/uL
Two out of three of the following (in peripheral blood): neutrophils less than 0.5 x 10^9/L; platelets less than 20 x 10^9/L; reticulocytes less than 20 x 10^9/L
Neutrophils < 1,500/µL
Neutrophils >= 1500/uL
Neutrophils < 1.5 x 10^9/L
Neutrophils >= 1000/uL, obtained within 14 days of the first dose of study drug
Neutrophils less than 1.5 x 10^9/L
Absolute Neutrophils > 1.5 x 109/L
